AV
WST icon

ASR Vermogensbeheer’s West Pharmaceutical WST Stock Holding History

ASR Vermogensbeheer’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Buy
10,024
+349
+4% +$107K 0.04% 319
2026
Q1 		$2.43M Buy
9,675
+162
+2% +$40.3K 0.03% 341
2025
Q4 		$2.62M Sell
9,513
-82
-0.9% -$22.4K 0.03% 335
2025
Q3 		$2.52M Sell
9,595
-35
-0.4% -$8.51K 0.03% 335
2025
Q2 		$2.11M Sell
9,630
-36
-0.4% -$7.7K 0.03% 356
2025
Q1 		$2.16M Buy
+9,666
New +$2.66M 0.03% 324

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ASR Vermogensbeheer's WST Position: Q2 2026 in Review

ASR Vermogensbeheer increased its West Pharmaceutical (WST) stake by 3.6% in Q2 2026, buying an estimated $107K and bringing the position to 10,024 shares worth $3.6M. The position accounts for 0.04% of the portfolio, ranked #319.

ASR Vermogensbeheer first reported a position in WST in Q1 2025 and has held it in 6 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • ASR Vermogensbeheer held 10,024 shares of West Pharmaceutical worth $3.6M as of Q2 2026.
  • ASR Vermogensbeheer bought 349 West Pharmaceutical shares in Q2 2026, an estimated $107K.
  • West Pharmaceutical made up 0.04% of ASR Vermogensbeheer's portfolio in Q2 2026, its #319 holding.
  • ASR Vermogensbeheer first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.